Market Cap ₹1319 Cr.
Stock P/E 7.7
P/B 1.9
Current Price ₹557.9
Book Value ₹ 290.3
Face Value 10
52W High ₹1374
Dividend Yield 0.54%
52W Low ₹ 453.8
Best Agrolife Ltd (Best Agrolife) is an totally India-based agrochemical employer. The Company is targeted on presenting crop protection and meals protection solutions to farmers. Best Agrolife offers more than 70 formulations from its in-house manufactured active elements, which can be insecticides, herbicides, fungicides and plant-growth regulators. Its insecticide products include PYMAX, DIRON, CUBAX, IRAM, MAHABALI, and NOVOXA. The Company's herbicide products consist of BYJU, VYPYR, Q-FOP 10, MAJOUR, PM-32, GUSTO and PUTIN. Its fungicide product portfolio consists of SULU, TEBUCA, D-ZOLE, BESTLINE, CAPRCHA, ZOXIT, ZODIO, and ISOCURE. Its plant-growth regulators include MIXWELL, PACLOK, ZIPPY GOLD, RICHGROW, and MYCORISER.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 324 | 232 | 309 | 464 | 700 | 328 | 254 | 612 | 811 | 315 |
| Other Income | 0 | -0 | 1 | 0 | 1 | 1 | 1 | 4 | -3 | 1 |
| Total Income | 325 | 232 | 310 | 464 | 701 | 328 | 255 | 617 | 808 | 315 |
| Total Expenditure | 289 | 200 | 247 | 398 | 518 | 270 | 247 | 482 | 667 | 296 |
| Operating Profit | 36 | 32 | 63 | 66 | 183 | 59 | 8 | 134 | 141 | 19 |
| Interest | 2 | 5 | 7 | 7 | 9 | 10 | 13 | 12 | 15 | 19 |
| Depreciation | 1 | 3 | 7 | 6 | 6 | 6 | 7 | 7 | 8 | 6 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 33 | 23 | 49 | 53 | 168 | 43 | -12 | 115 | 118 | -6 |
| Provision for Tax | 8 | 8 | 11 | 13 | 38 | 12 | -3 | 24 | 23 | 0 |
| Profit After Tax | 25 | 15 | 38 | 40 | 130 | 31 | -8 | 91 | 95 | -7 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Adjustments | 25 | 15 | 38 | 40 | 130 | 31 | -8 | 91 | 95 | -7 |
| Adjusted Earnings Per Share | 11.4 | 6.5 | 16.1 | 17 | 54.9 | 12.9 | -3.6 | 38.3 | 40.1 | -2.8 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|
| Net Sales | 99 | 129 | 905 | 1211 | 1746 | 1992 |
| Other Income | 0 | 4 | 7 | 2 | 3 | 3 |
| Total Income | 99 | 133 | 913 | 1213 | 1748 | 1995 |
| Total Expenditure | 98 | 132 | 854 | 1045 | 1432 | 1692 |
| Operating Profit | 1 | 1 | 58 | 168 | 316 | 302 |
| Interest | 1 | 1 | 5 | 15 | 39 | 59 |
| Depreciation | 0 | 0 | 3 | 12 | 25 | 28 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 51 | 141 | 253 | 215 |
| Provision for Tax | 0 | 0 | 14 | 36 | 61 | 44 |
| Profit After Tax | -0 | -0 | 37 | 105 | 192 | 171 |
| Adjustments | -3 | 2 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -3 | 2 | 37 | 105 | 192 | 171 |
| Adjusted Earnings Per Share | -0.4 | -0.1 | 16.8 | 44.3 | 81.3 | 72 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 44% | 138% | 0% | 0% |
| Operating Profit CAGR | 88% | 581% | 0% | 0% |
| PAT CAGR | 83% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -45% | 22% | 67% | NA% |
| ROE Average | 46% | 45% | 27% | 27% |
| ROCE Average | 35% | 42% | 26% | 26% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| Shareholder's Funds | 54 | 56 | 130 | 330 | 527 |
| Minority's Interest | 2 | 2 | 0 | 0 | 0 |
| Borrowings | 0 | 8 | 3 | 49 | 34 |
| Other Non-Current Liabilities | -1 | -0 | 6 | 20 | 22 |
| Total Current Liabilities | 62 | 44 | 243 | 618 | 904 |
| Total Liabilities | 116 | 109 | 381 | 1017 | 1487 |
| Fixed Assets | 0 | 0 | 19 | 180 | 203 |
| Other Non-Current Assets | 32 | 3 | 5 | 7 | 66 |
| Total Current Assets | 83 | 106 | 355 | 830 | 1218 |
| Total Assets | 116 | 109 | 381 | 1017 | 1487 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 1 | 10 | 21 | 13 |
| Cash Flow from Operating Activities | -14 | -41 | 13 | -60 | -180 |
| Cash Flow from Investing Activities | -34 | 31 | 8 | -15 | -19 |
| Cash Flow from Financing Activities | 48 | 10 | -11 | 67 | 248 |
| Net Cash Inflow / Outflow | 0 | -0 | 10 | -8 | 49 |
| Closing Cash & Cash Equivalent | 1 | 0 | 21 | 13 | 62 |
| # | Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.44 | -0.08 | 16.83 | 44.31 | 81.26 |
| CEPS(Rs) | -0.23 | 0.41 | 18.17 | 49.31 | 91.63 |
| DPS(Rs) | 0.1 | 0.1 | 2 | 2 | 3 |
| Book NAV/Share(Rs) | 159.19 | 166.95 | 56.85 | 138.4 | 217.62 |
| Core EBITDA Margin(%) | 1.05 | -2.26 | 5.19 | 12.71 | 16.22 |
| EBIT Margin(%) | 1.22 | 0.79 | 5.63 | 11.94 | 15.09 |
| Pre Tax Margin(%) | 0.03 | 0.03 | 5.15 | 10.78 | 13.08 |
| PAT Margin (%) | -0.14 | -0.02 | 3.76 | 8.03 | 9.94 |
| Cash Profit Margin (%) | -0.07 | 0.1 | 4.06 | 8.94 | 11.2 |
| ROA(%) | -0.12 | -0.02 | 15.11 | 14.98 | 15.35 |
| ROE(%) | -0.28 | -0.05 | 42.05 | 46.31 | 45.65 |
| ROCE(%) | 2.25 | 1.6 | 48.89 | 41.87 | 35.07 |
| Receivable days | 108.83 | 92.68 | 30.93 | 54.16 | 57.07 |
| Inventory Days | 36.34 | 47.91 | 32.88 | 85.1 | 109.79 |
| Payable days | 116.23 | 83.28 | 42.32 | 83.11 | 85.42 |
| PER(x) | 0 | 0 | 26.48 | 20.21 | 12.6 |
| Price/Book(x) | 0.22 | 0.02 | 7.84 | 6.47 | 4.71 |
| Dividend Yield(%) | 0.29 | 3.8 | 0.45 | 0.22 | 0.29 |
| EV/Net Sales(x) | 0.1 | 0.15 | 1.08 | 1.93 | 1.66 |
| EV/Core EBITDA(x) | 7.91 | 16.23 | 16.69 | 13.97 | 9.14 |
| Net Sales Growth(%) | 0 | 30.29 | 600.89 | 33.72 | 44.18 |
| EBIT Growth(%) | 0 | -15.51 | 5312.29 | 180.52 | 87.32 |
| PAT Growth(%) | 0 | 82.75 | 0 | 182.56 | 83.41 |
| EPS Growth(%) | 0 | 82.75 | 0 | 163.29 | 83.41 |
| Debt/Equity(x) | 0.01 | 0.37 | 0.22 | 0.81 | 1.08 |
| Current Ratio(x) | 1.35 | 2.44 | 1.46 | 1.34 | 1.35 |
| Quick Ratio(x) | 1.26 | 2.11 | 0.83 | 0.61 | 0.56 |
| Interest Cover(x) | 1.03 | 1.04 | 11.72 | 10.32 | 7.51 |
| Total Debt/Mcap(x) | 0.03 | 23.26 | 0.03 | 0.12 | 0.23 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 45.42 | 45.42 | 47.3 | 47.3 | 48.2 | 50.1 | 50.1 | 50.1 | 50.1 | 50.1 |
| FII | 11.22 | 11.31 | 10.82 | 11.27 | 12.05 | 11.48 | 10.83 | 9.86 | 8.85 | 8.77 |
| DII | 0.19 | 0.19 | 0.19 | 2.57 | 2.58 | 2.58 | 2.56 | 2.63 | 2.54 | 2.54 |
| Public | 43.17 | 43.08 | 41.68 | 38.85 | 37.17 | 35.84 | 36.51 | 37.41 | 38.51 | 38.59 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.07 | 1.07 | 1.12 | 1.12 | 1.14 | 1.18 | 1.18 | 1.18 | 1.18 | 1.18 |
| FII | 0.27 | 0.27 | 0.26 | 0.27 | 0.28 | 0.27 | 0.26 | 0.23 | 0.21 | 0.21 |
| DII | 0 | 0 | 0 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Public | 1.02 | 1.02 | 0.99 | 0.92 | 0.88 | 0.85 | 0.86 | 0.88 | 0.91 | 0.91 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 | 2.36 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
